Lower Risk Across All Key Outcomes with GLP-1RA Compared with DPP-4 inhibitors, GLP-1RA use was associated with significantly lower risks of MACE (hazard ratio [HR]: 0.66), VTE (HR: 0.49), kidney disease progression (HR: 0.77), and all-cause mortality (HR: 0.26)
Because they are supplements rather than prescription medications, systemic side effects are less defined, but the lack of clinical testing means overall safety remains uncertain
Cost savings that comes down the road Economists say that, yes, the medications are expensive, but they could also lead to substantial cost savings if they prevent other serious medical conditions like heart disease, diabetes and arthritis
The study authors concluded that effects were greater at doses at or over 3 grams daily
Insert and Remove the Needle Slow and Steadily Quick jabs or forceful insertions increase the chance of hitting small blood vessels and forming a hematoma
Department of Dermatology